Hilal Özakıncı

Also affiliated with Moffitt Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer”.

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101852

N/A

0.396DataRank · unranked

13 citations

Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar +13 more

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.101944

N/A

0.208DataRank · unranked

3 citations

Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar +13 more

Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung Adenocarcinoma

The Journal of Immunology(2024)10.4049/jimmunol.2400234

N/A

0DataRank · unranked

0 citations

Xiaofei Song, Gina S. Nazario, Thomas Lila, Benjamin K. Chen, Tyler R. Simpson +13 more

Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancers

Research Square(2025)10.21203/rs.3.rs-6264377/v1

N/A

0DataRank · unranked

3 citations

Bina Desai, Tatiana Miti, Sandhya Prabhakaran, Daria Miroshnychenko, M Henry +12 more